Maternal Serum
Testing (Triple Marker)
The California Expanded AFP (XAFP) program
is administered by the California DHS
Genetic Disease Branch (GDB)
2151 Berkeley Way, Annex 4
Berkely, Ca 94704
510-540-2534
FAX: 510-540-2966 or 510-540-2095
REFERRAL
Patients may be
referred to a prenatal diagnosis center for
-
Singleton > 2.5 MoM for NTD
-
Twins with > 4.5 multiples of the median (MoM) for NTD
-
Twin with one demised twin where demise occurred less than 3 weeks from
the time of blood collection with > 4.5 MoM for NTD
-
Twin with one demised twin where demise occurred greater than or equal 3
weeks at blood collection with > 2.5 MoM for NTD (same as singleton)
-
Risk
for Down syndrome 1 in 190 on the XAFP screen
-
Risk
for trisomy 18 (Edward syndrome) 1 in 100 on the XAFP screen
-
Risk for
Smith-Lemli-Opitz syndrome 1 in 50 on the XAFP screen.
-
H/O neural tube defect (NTD):
-
Previous child with an NTD
-
sibling or half-sibling of fetus with an NTD
-
parent of a fetus with an NTD
- Two second degree relatives of a fetus with an
NTD.
- A history of exposure to valproic
acid( Depakote, Depakene) or carbamazepine (Tegretol, Carbatrol) during the
first trimester or one month prior to conception.
DATING RULES
-
The computer program uses gestational date, diabetes,
weight, and race to adjust the MoM.
- The computer uses in order of
preference the ultrasound date >LMP > the exam to calculate the gestational
age. For screening purposes the biparietal
diameter (BPD) is preferable to a composite gestational age measurement
- Screen Positive for Neural tube defect (NTD)/
Abdominal wall defect (AWD )
-
if > 14 days, must recalculate the XAFP
result
-
if 8-13 days, up to individual prenatal diagnosis
center (PDC)
-
if 7 days or less, recalculation not allowed
- Screen Positive for T21
-
if > 14 days, must recalculate XAFP result
-
if 0-13 days, up to individual PDC
-
Screen Positive for T18
-
no dating changes allowed
-
Screen positive for more than one indication
-
T21 and T18: follow the T18 redating rules
-
NTD and T8 follow the T18 redating rules
-
NTD and T21: follow the T21 rules
Decimal/weeks to Days Conversion
| Decimal weeks |
Days |
| 16.1 |
1 day |
| 16.2 |
1 day |
| 16.3 |
2 days |
| 16.4 |
3 days |
| 16.5 |
4 days |
| 16.6 |
4 days |
| 16.7 |
5 days |
| 16.8 |
6 days |
| 16.9 |
6 days |
OVERALL DETECTION RATES (DR)
| |
Overall DR |
Screen Positive |
| Down syndrome |
66% * |
5.6% |
| Neural Tube Defects |
|
1.72% |
| Open Spina Bifida |
80% |
|
| Anencephaly |
97% |
|
| Abdominal Wall Defects |
85% |
|
| Trisomy 18 |
60% |
0.41% |
DOWN SYNDROME DETECTION RATE (DR) TRIPLE MARKER
|
Maternal Age
(at term) |
Detection
Rate |
Screen
Positive
Rate |
| < 20 |
40 |
2.4 |
| 21 |
41 |
2.4 |
| 22 |
41 |
2.4 |
| 23 |
42 |
2.7 |
| 24 |
43 |
2.8 |
| 25 |
44 |
3.0 |
| 26 |
45 |
3.2 |
| 27 |
46 |
3.4 |
| 28 |
47 |
3.7 |
| 29 |
50 |
4.2 |
| 30 |
52 |
4.8 |
| 31 |
55 |
5.9 |
| 32 |
58 |
6.9 |
| 33 |
62 |
9.0 |
| 34 |
66 |
10.2 |
| 35 |
71 |
12.9 |
| 36 |
75 |
16.2 |
| 37 |
79 |
20 |
| 38 |
83 |
25 |
| 39 |
87 |
30 |
| 40 |
90 |
36 |
| 41 |
92 |
43 |
| 42 |
95 |
50 |
| 43 |
96 |
58 |
| 44 |
99 |
86 |
| 45 |
99 |
89 |
| > 46 |
99 |
95 |
The most common cause of any abnormal screen is
inaccurate gestational dating.
For twin gestations a risk estimate is given for Down
syndrome, but the estimate is not as accurate as for a singleton. No risk
estimate is given for trisomy 18.
RESULTS OF XAFP
|
POSSIBLE CONDITION
|
MATERNAL SERUM SCREENING PATTERN
|
|
alpha-fetoprotein
(AFP)
|
human chorionic gonadotropin (hCG)
|
Unconjugated estradiol
(uE3)
|
|
Fetal death, open spina bifida,
abdominal wall defects
|
high
|
normal
|
normal
|
|
Anencephaly
|
high
|
normal
|
low
|
|
Dates more advanced
|
high
|
low
|
high
|
|
Fetal death , x-linked ichthyosis
(placental sulfatase deficiency) congenital adrenal hypoplasia
|
normal
|
normal
|
very
low
|
|
Down syndrome, dates less advanced,
Turner syndrome with cystic hygroma
|
low
|
high
|
low
|
|
Trisomy 18
|
low
|
low
|
low
|
|
PREGNANCY COMPLICATIONS WITH UNEXPLAINED
RESULTS |

MSAFP > 2.5 MoM |
| |
Fetal/perinatal death, prematurity, growth restriction, oligohydramnios |
| MSAFP
> 2.5 AND hCG > 2.0 MoM |
| |
Hypertension,
preeclampsia, premature rupture of membranes, IUGR, abruptio placentae, and
perinatal death.
The combination of both has at least a 50% risk
of complications. |
| uE3 < 0.15 MoM |
| |
Fetal death,
x-linked ichthyosis, congenital adrenal hypoplasia, anencephaly, Smith-Lemli-Opitz
syndrome. |
RECOMMENDATIONS FOR FOLATE
- 400 micrograms daily for all women of childbearing age.
- 4 milligram daily two months prior to conception and during the the
first trimester for women with a previous pregnancy complicated by neural
tube defect (NTD)
REFERENCE:Expanded AFP Screening Program Prenatal Care Provider Handbook.
Sacramento, CA: California Department of Health Services, Genetic Disease Branch; 1997.
RECURRENCE
RISK(%) FOR COMMON MULTIFACTORIAL CONDITIONS [5]
|
CONDITION |
AFFECTED
RELATIVE(S) |
|
None |
One sibling or parent* |
2
Siblings or one sibling and one parent |
|
Cleft
lip with or without palate |
0.1 |
4 |
10-11 |
|
Cleft
palate only |
0.04 |
2-7 |
15 |
|
Anencephaly |
0.1 |
3 |
8 |
|
Meningomyelocele |
0.1 |
3 |
8 |
|
Congenital
heart disease any |
0.3 |
4-5
|
10-11 |
|
Ventricular
septal defect |
|
3-4 |
10 |
|
Patent
ductus arteriosus |
|
3-4 |
10 |
|
Atrial
septal defects |
|
2-3 |
8 |
|
Tetralogy of Fallot |
|
2-3 |
8 |
|
Pulmonary
stenosis |
|
2-3 |
6 |
|
Aortic
stenosis |
|
2-3 |
6 |
|
Hypoplastic
left heart |
|
2 |
6 |
*For congenital heart disease if the
mother is the affected parent the risk is as for two sibs
COUNSELING:
For
multifactorial conditions, ask the parents if they have any ideas regarding
the cause of the defect. The developmental pathology of the defect should
be explained to the parents . Explain that the recurrence risk for a similar
defect is generally 3 to 5 % (or the square root of the population incidence)
if one offspring is affected. The recurrence risk is increased if:
There is more than
one affected relative.
The defect is severe.
The trait is more
frequent in one sex than the other,and the affected person is of the sex
less likely to be affected
There is consanguinity.
The risk to a
second degree relative (includes half brother or sister) is closer to the
population incidence.
REFERENCES
1. Cuckle HA, Wald NJ, Thompson SC.Estimating
a woman’s risk of having a pregnancy associated with Down’s syndrome using
her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987 94:387
2. Data from (1) adjusted for 23% loss
rate: Hook, EB. Chromosome abnormalities and spontaneous fetal deaths following
amniocentesis:further data and associations with maternal age. Am J Hum
Genet 1983 35:110-116
3. Estimate from Foundation for Blood
Research
4. Hook EB, Cross PK, Schreinemachers
DM.Chromosomal abnormality rates at amniocentesis and in live-born infants.
JAMA 1983 249:2034-203
5. Laxova R, Feldman PF.
General Genetics Principles: Chromosomal, Mendelian, and Principles of
Teratology. In: ed Gleicher N Principles and Practice of Medical
Therapy in Pregnancy Norwalk CT: Appleton & Lange, 1992. p143.
|